Glucagonoma (Glucagopota)

Glucagonoma (Glucagosweat) is a rare disease associated with a tumor of the pancreas that secretes the hormone glucagon. Glucagonoma can lead to serious health problems because glucagon increases blood glucose levels, which can lead to hypoglycemia.

Hypoglycemia is a condition in which blood glucose levels drop to low levels, which can lead to serious consequences such as seizures, unconsciousness, and even coma. Glucagonoma can cause hypoglycemia because the tumor produces glucagon regardless of blood glucose levels.

Symptoms of glucagonoma vary and depend on how high the level of glucagon is in the blood. Some of the most common symptoms of glucagonoma include:

1. Dizziness
2. Feeling hungry
3. Fast pulse
4. Frequent urination
5. Weakness and fatigue
6. Unexplained weight

If you suspect glucagonoma, you should consult a doctor. The doctor may order a number of tests, including blood tests and educational studies, to detect the presence of a pancreatic tumor. If glucagonoma is confirmed, treatment may include surgical removal of the tumor or drug therapy.

Overall, glucagonoma is a rare disease, but it can have serious health consequences. If you suspect glucagonoma, you should see a doctor for diagnosis and treatment. It is important to remember that timely detection and treatment of glucagonoma can significantly reduce the risk of developing hypoglycemia and other complications.

Glucagonoma or glucagonoma is a tumor of the endocrine tissue of pancreatic cells that respond to glucose and release glucagon molecules into the bloodstream. In most cases, the tumors are called "insulomas", by analogy with the insulin that the pancreas produces, due to the poor connection between diabetes and glucagonomy.

A person diagnosed with glucogonoma may experience quite severe hypoglycemia (low blood sugar), which can lead to hunger, visual disturbances, coma and death. Doctors became concerned when they learned about another pancreatic cancer - glucose. He

Glucagonoma is a type of pancreatic tumor that exhibits the formation of the tumor hormone glucagon. The glucagon hormone is responsible for managing blood glucose levels; its hypersynthesis leads to the development of a condition associated with a sharp decrease in blood glucose levels - hypoglycemia.

Specific diagnostics make it possible to identify which part of the patient’s pancreas is affected. Among the types of excision are:

1. Palliative removal - carried out in case of frequent exacerbations, or in cases where it is impossible to remove the tumor surgically. Drug treatment for this pathology is not effective. 2. Endoscopic excision of the tumor is carried out in the initial stages, since the intervention is minimally invasive. On the monitor, a special tube - an endoscope - is expanded and the tumor is pinched off. Finally, special healing preparations are injected into the cavity. 3. The procedure for palliative resection of the gland is also carried out without removing it. Only the affected part – segments of the gland – is removed. This is the most common type of surgery. In this case, different lobes of the gland are affected. Complications after this procedure are common. After such an intervention, there is a high probability of weakened immunity and relapse. After about 5 months, obstruction occurs. It is difficult to cure this condition. Most often, patients have to take hormones for the rest of their lives. The duct may become twisted and clogged with a stone. All these complications lead to intoxication. The patient's condition depends on which part of the gland is affected. In case of damage to her body, it is possible to normalize glucose levels with drug treatment.

Glucagonomas are tumors of the pancreas (pancreatogenic tumor) that secrete glucagon (a biologically active hormone) in the human body. This disease is an endocrine disorder that can lead to severe hypoglycemia if not treated promptly.

Glucagon is a hormone produced by cells in the pancreas and is essential for controlling blood sugar levels. Increased glucagon secretion can lead to a hypoglycemic state, where blood sugar levels drop to dangerous levels. Symptoms of this condition may include dizziness, weakness and confusion.

Glucagonomas are malignant tumors that arise in the cells of the pancreas. In this case, intensive production of glucagon occurs. Accordingly, the patient develops uncontrolled hyperglycemia and the development of diabetes mellitus due to a sharp increase in the concentration of glucose in the blood. Hyperinsulinemia may also occur because insulin does not perform its function of lowering blood sugar. This hormone is secreted by the pancreas to protect itself, but insulin levels still decrease due to the formation of this hormone in pathology.

Glucagonoma occurs in adulthood and is a rare disease. It is characterized by gradual development and consistent manifestation of symptoms, so it is very difficult to detect the disease at the initial stage